These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 7518782
1. Butyrate is a potent inhibitor of urokinase secretion by normal colonic epithelium in vitro. Gibson PR, Rosella O, Rosella G, Young GP. Gastroenterology; 1994 Aug; 107(2):410-9. PubMed ID: 7518782 [Abstract] [Full Text] [Related]
2. Colonic epithelial cell activation and the paradoxical effects of butyrate. Gibson PR, Rosella O, Wilson AJ, Mariadason JM, Rickard K, Byron K, Barkla DH. Carcinogenesis; 1999 Apr; 20(4):539-44. PubMed ID: 10223179 [Abstract] [Full Text] [Related]
3. Secretion of urokinase and plasminogen activator inhibitor-1 by normal colonic epithelium in vitro. Gibson P, Rosella O, Rosella G, Young G. Gut; 1994 Jul; 35(7):969-75. PubMed ID: 8063226 [Abstract] [Full Text] [Related]
4. Short chain fatty acids inhibit human (SW1116) colon cancer cell invasion by reducing urokinase plasminogen activator activity and stimulating TIMP-1 and TIMP-2 activities, rather than via MMP modulation. Emenaker NJ, Basson MD. J Surg Res; 1998 Apr; 76(1):41-6. PubMed ID: 9695737 [Abstract] [Full Text] [Related]
5. Sodium butyrate differentially modulates plasminogen activator inhibitor type-1, urokinase plasminogen activator, and its receptor in a human colon carcinoma cell. Reeder JA, Dickinson JL, Chenevix-Trench G, Antalis TM. Teratog Carcinog Mutagen; 1993 Apr; 13(2):75-88. PubMed ID: 8102211 [Abstract] [Full Text] [Related]
6. Butyrate regulates gene expression of the plasminogen activating system in colon cancer cells. Antalis TM, Reeder JA. Int J Cancer; 1995 Sep 04; 62(5):619-26. PubMed ID: 7665235 [Abstract] [Full Text] [Related]
7. Divergent phenotypic patterns and commitment to apoptosis of Caco-2 cells during spontaneous and butyrate-induced differentiation. Mariadason JM, Rickard KL, Barkla DH, Augenlicht LH, Gibson PR. J Cell Physiol; 2000 Jun 04; 183(3):347-54. PubMed ID: 10797309 [Abstract] [Full Text] [Related]
8. Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease. Gibson P, Rosella O. Gut; 1995 Oct 04; 37(4):536-43. PubMed ID: 7489942 [Abstract] [Full Text] [Related]
9. Transforming growth factor beta 1 and sodium butyrate differentially modulate urokinase plasminogen activator and plasminogen activator inhibitor-1 in human breast normal and cancer cells. Dong-Le Bourhis X, Lambrecht V, Boilly B. Br J Cancer; 1998 Oct 04; 77(3):396-403. PubMed ID: 9472634 [Abstract] [Full Text] [Related]
10. Role of urokinase and its receptor in basal and stimulated colonic epithelial cell migration in vitro. Wilson AJ, Gibson PR. Gut; 2000 Jul 04; 47(1):105-11. PubMed ID: 10861271 [Abstract] [Full Text] [Related]
11. Effect of short-chain fatty acids on the human colonic mucosa in vitro. Scheppach W, Bartram P, Richter A, Richter F, Liepold H, Dusel G, Hofstetter G, Rüthlein J, Kasper H. JPEN J Parenter Enteral Nutr; 1992 Jul 04; 16(1):43-8. PubMed ID: 1738218 [Abstract] [Full Text] [Related]
19. Sodium butyrate inhibits expression of urokinase and its receptor mRNAs at both transcription and post-transcription levels in colon cancer cells. Dang J, Wang Y, Doe WF. FEBS Lett; 1995 Feb 13; 359(2-3):147-50. PubMed ID: 7867787 [Abstract] [Full Text] [Related]
20. Dietary modulation of colonic mucosal urokinase activity in rats. Gibson P, Folino M, McIntyre A, Rosella O, Finch C, Young G. J Gastroenterol Hepatol; 1995 Feb 13; 10(3):324-30. PubMed ID: 7548811 [Abstract] [Full Text] [Related] Page: [Next] [New Search]